Correction: Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients with Narcolepsy: A Commentary
Neurol Ther
.
2024 Aug;13(4):1315-1319.
doi: 10.1007/s40120-024-00606-9.
Authors
Russell Rosenberg
1
,
Rogelio Braceras
2
,
Wayne Macfadden
2
,
Shawn Candler
2
,
Jed Black
3
4
,
Chad Ruoff
5
Affiliations
1
NeuroTrials Research, Inc., Atlanta, GA, USA.
2
Jazz Pharmaceuticals, Philadelphia, PA, USA.
3
Center for Sleep Sciences and Medicine, Stanford University, Palo Alto, CA, USA.
4
Jazz Pharmaceuticals, Palo Alto, CA, USA.
5
Division of Pulmonary Medicine, Mayo Clinic, 13400 East Shea Boulevard, Scottsdale, AZ, 85259, USA. Ruoff.Chad@mayo.edu.
PMID:
38913322
PMCID:
PMC11263271
DOI:
10.1007/s40120-024-00606-9
No abstract available
Publication types
Published Erratum